Pages that link to "Q50943637"

The following pages link to LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer (Q50943637):

Displaying 13 items.

• CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer (Q34277349) (← links)
• In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance (Q34999663) (← links)
• Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients. (Q37046528) (← links)
• Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells (Q37597429) (← links)
• Role of LAP+CD4+ T cells in the tumor microenvironment of colorectal cancer (Q37624495) (← links)
• Immune classification of colorectal cancer patients: impressive but how complete? (Q38071673) (← links)
• PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation (Q38622789) (← links)
• Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis (Q39601654) (← links)
• MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells (Q40987678) (← links)
• Targeting latency-associated peptide promotes antitumor immunity. (Q42626385) (← links)
• Home sweet home: the tumor microenvironment as a haven for regulatory T cells. (Q43090164) (← links)
• Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells. (Q53021850) (← links)
• LAPCD4 T cells are elevated among the peripheral blood mononuclear cells and tumor tissue of patients with hepatocellular carcinoma (Q59354392) (← links)